SPOTLIGHT: Energy Star to benchmark pharma efficiency

Big Pharma has been working with Energy Star to measure energy usage at various facilities and develop best practices for energy efficiency. Coming soon: a new benchmarking tool able to rate energy efficiency of individual pharma plants against industry averages. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.